LONDON, August 26, 2010 /PRNewswire/ -- Hikma
Pharmaceuticals reports half year profit growth and raises gross
margin guidance.
In a video interview on www.cantos.com, Hikma CEO Said Darwazah says a good performance at the
company's three divisions supported the results. "All three engines
have been performing quite well, to give us these fantastic
results."
The Generic drugmaker's Chief Financial Officer, Bassam Kaanan,
added that the company was financially strong. "We do have plenty
of room to finance our organic growth and also to move very
aggressively on our acquisition strategy."
The interview and transcript are available now on
http://www.cantos.com.
Cantos.com, the online financial broadcaster, features in-depth
interviews, documentaries and webcasts with senior company
executives. If you would like to contact us, please email
amanda.alexander@cantos.com or phone +44-207-936-1352.